In Reply We agree with Drs Ross and Krumholz that this initial examination reflects only the early days of the open access movement, and there is a need to track trends in use over time. One aim of our publication was in fact to promote knowledge regarding the availability of these trials data and to encourage broader use.
Ross and Krumholz are correct that at the time of publication, the SOAR Initiative, the newest of the 3 data platforms studied, did not yet have a public website that provided information on the status of requests and approvals. Since publication, SOAR has launched a public website with this information (http://soar.dcri.org), and plans to expand these data are under way.
Navar AM, Pencina MJ, Peterson ED. Open Access Platforms for Sharing Clinical Trial Data—Reply. JAMA. 2016;316(6):666–667. doi:10.1001/jama.2016.8797
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.